Bain Capital Life Sciences Investors, LLC: 13F holdings
CIK 17030312026Q2
| Positions | 21 |
|---|---|
| Reported value | $1.7bn |
| Filed | 2026-08-14 |
Top 10 holdings
| Security | Shares | Value | Weight |
|---|---|---|---|
| KAILERA THERAPEUTICS INC | 22,583,268 | $497.5m | 29.6% |
| HEARTFLOW INC | 8,448,158 | $247.9m | 14.7% |
| NEWAMSTERDAM PHARMA COMPANY | 3,806,566 | $129.0m | 7.7% |
| SAVARA INC | 17,600,621 | $108.4m | 6.4% |
| ALKERMES PLC | 1,937,938 | $101.5m | 6.0% |
| SOLID BIOSCIENCES INC | 9,808,819 | $98.0m | 5.8% |
| PHARVARIS N V | 2,675,509 | $92.5m | 5.5% |
| OLEMA PHARMACEUTICALS INC | 7,085,249 | $88.6m | 5.3% |
| HEMAB THERAPEUTICS HOLDINGS INC | 1,650,000 | $60.6m | 3.6% |
| CABALETTA BIO INC | 17,241,445 | $53.6m | 3.2% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1703031")Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.